$HUMA SEC Filings

Filed On	Filing
07 Oct 2026	Form 4: Kuznik Paul Brian, Director Granted 125,000 Stock Options (right to buy)
07 Oct 2026	Form 4: Coward D Scott, Director Granted 125,000 Stock Options (right to buy)
28 Sep 2026	Form 3: Kuznik Paul Brian, Director Holds 65,719 shares of Common Stock
28 Sep 2026	Form 3: Coward D Scott, Director No securities owned
28 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
15 Sep 2026	Form 4: Jones Keith Anthony, Director Bought 10,000 shares ($5.62K)
25 Aug 2026	25-NSE
21 Aug 2026	Form 4: Jones Keith Anthony, Director Bought 10,000 shares ($6.93K)
19 Aug 2026	Form 4: Jones Keith Anthony, Director Bought 30,000 shares ($17.8K)
18 Aug 2026	SCHEDULE 13D/A
12 Aug 2026	10-Q
12 Aug 2026	8-K: Results of Operations and Financial Condition
31 Jul 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
28 Jul 2026	SCHEDULE 13G/A
13 Jul 2026	SCHEDULE 13D/A
22 Jun 2026	SCHEDULE 13G
15 Jun 2026	SCHEDULE 13D/A
12 Jun 2026	Form 4: Windham-Bannister Susan Richards, Director Granted 80,000 Stock Options (right to buy)
12 Jun 2026	Form 4: Constantino Michael T., Director Granted 80,000 Stock Options (right to buy)
12 Jun 2026	Form 4: Wallace Max N., Director Granted 80,000 Stock Options (right to buy)

Comments